Racial Differences in COVID-19 Infection Rates Among PWH in the United States

March 6-10, 2021; Virtual
Racial and ethnic disparities are evident among PWH testing positive for COVID-19 in the United States.
Format: Microsoft PowerPoint (.ppt)
File Size: 182 KB
Released: March 12, 2021

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Gilead Sciences
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.
ViiV Healthcare

Related Content

Slides from CCO: Switching ART in HIV: 3-drug therapy, oral 2-drug options, long-acting injectable 2-drug regimens, single tablet regimens (STRs)

Daniel R. Kuritzkes, MD Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: June 7, 2021

Latesha Elopre and CCO: starting HIV pre-exposure prophylaxis (PrEP). DISCOVER study, CDC guidance, racial/ethnic disparities, overcoming barriers

Latesha Elopre, MD, MSPH Released: June 7, 2021

Slides from Latesha Elopre and CCO: starting HIV preexposure prophylaxis (PrEP). DISCOVER study, CDC guidance, racial/ethnic disparities, overcoming barriers.

Latesha Elopre, MD, MSPH Released: June 7, 2021

Free expert slides from Clinical Care Options (CCO) reviewing the use of HIV-ASSIST to guide ART in a treatment-experienced patient with comorbidities

Ethel D. Weld, MD, PhD Released: May 27, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue